News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...
Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...
(Reuters) -Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results